DNA methylation associated with polycomb repression in retinoic acid receptor β silencing

FASEB Journal

Volumn 27, Issue 4, 2013, Pages 1468-1478

  Moison, Céline ^a,b,c,d   Senamaud Beaufort, Catherine ^b,c   Fourrière, Lou ^b,c,d   Champion, Christine ^b,c,d   Ceccaldi, Alexandre ^b,c,d   Lacomme, Stéphanie ^e   Daunay, Antoine ^f   Tost, Jörg ^f,g   Arimondo, Paola B ^a   Guieysse Peugeot, Anne Laure ^b,c  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b CNRS   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f FONDATION JEAN DAUSSET CEPH   (France)

^g DIF   (France)

Author keywords

DNA hypermethylation; Epigenetic silencing; EZH2; Prostate cancer; Tumor supressor gene

Indexed keywords

POLYCOMB GROUP PROTEIN; RETINOIC ACID RECEPTOR BETA;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETIC REPRESSION; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN MICROARRAY; RETINOIC ACID RECEPTOR BETA 2; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

AZACITIDINE; CELL LINE, TUMOR; CHROMATIN; CPG ISLANDS; DNA METHYLATION; ENZYME INHIBITORS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONES; HUMANS; NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID;

EID: 84875732221     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-210971     Document Type: Article

References (61)

1. Feinberg, A. P. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433-440.
2. Weber, M., and Schubeler, D. (2007) Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr. Opin. Cell Biol. 19, 273-280.
3. Sharma, S., Kelly, T. K., and Jones, P. A. (2010) Epigenetics in cancer. Carcinogenesis 31, 27-36.
4. Evans, T. R., and Kaye, S. B. (1999) Retinoids: present role and future potential. Br. J. Cancer 80, 1-8.
5. Ross, S. A., McCaffery, P. J., Drager, U. C., and De Luca, L. M. (2000) Retinoids in embryonal development. Physiol. Rev. 80, 1021-1054.
6. Boncinelli, E., Simeone, A., Acampora, D., and Mavilio, F. (1991) HOX gene activation by retinoic acid. Trends Genet. 7, 329-334.
7. Langston, A. W., and Gudas, L. J. (1994) Retinoic acid and homeobox gene regulation. Curr. Opin. Genet. Dev. 4, 550-555.
8. Altucci, L., and Gronemeyer, H. (2001) The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1, 181-193.
9. Karamouzis, M. V., Konstantinopoulos, P. A., and Papavassiliou, A. G. (2007) The molecular basis of retinoids' use in breast cancer chemoprevention. Cell Oncol. 29, 183-184.
10. Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954.
11. Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S. J., and Swisshelm, K. (1995) Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 6, 1077-1088.
12. Liu, Y., Lee, M. O., Wang, H. G., Li, Y., Hashimoto, Y., Klaus, M., Reed, J. C., and Zhang, X. (1996) Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell Biol. 16, 1138-1149.
13. Faria, T. N., Mendelsohn, C., Chambon, P., and Gudas, L. J. (1999) The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J. Biol. Chem. 274, 26783-26788.
14. Houle, B., Rochette-Egly, C., and Bradley, W. E. (1993) Tumorsuppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. U. S. A. 90, 985-989.
15. Zelent, A., Mendelsohn, C., Kastner, P., Krust, A., Garnier, J. M., Ruffenach, F., Leroy, P., and Chambon, P. (1991) Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. EMBO J. 10, 71-81.
16. Houle, B., Pelletier, M., Wu, J., Goodyer, C., and Bradley, W. E. (1994) Fetal isoform of human retinoic acid receptor beta expressed in small cell lung cancer lines. Cancer Res. 54, 365-369.
17. Toulouse, A., Morin, J., Pelletier, M., and Bradley, W. E. (1996) Structure of the human retinoic acid receptor beta 1 gene. Biochim. Biophys. Acta 1309, 1-4.
18. Benbrook, D., Lernhardt, E., and Pfahl, M. (1988) A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333, 669-672.
19. De The, H., Vivanco-Ruiz, M. M., Tiollais, P., Stunnenberg, H., and Dejean, A. (1990) Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343, 177-180.
20. Nagpal, S., Zelent, A., and Chambon, P. (1992) RAR-beta 4, a retinoic acid receptor isoform is generated from RAR-beta 2 by alternative splicing and usage of a CUG initiator codon. Proc. Natl. Acad. Sci. U. S. A. 89, 2718-2722.
21. Chen, L. I., Sommer, K. M., and Swisshelm, K. (2002) Downstream codons in the retinoic acid receptor beta-2 and beta-4 mRNAs initiate translation of a protein isoform that disrupts retinoid-activated transcription. J. Biol. Chem. 277, 35411-35421.
22. Swift, M. E., Wallden, B., Wayner, E. A., and Swisshelm, K. (2006) Truncated RAR beta isoform enhances proliferation and retinoid resistance. J. Cell Physiol. 209, 718-72.
23. Peng, X., Maruo, T., Cao, Y., Punj, V., Mehta, R., Das Gupta, T. K., and Christov, K. (2004) A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells. Cancer Res. 64, 8911-8918.
24. Petty, W. J., Li, N., Biddle, A., Bounds, R., Nitkin, C., Ma, Y., Dragnev, K. H., Freemantle, S. J., and Dmitrovsky, E. (2005) A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. J. Natl. Cancer Inst. 97, 1645-1651.
25. Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., and Smith, H. S. (1996) Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274, 2057-2059.
26. Cote, S., and Momparler, R. L. (1997) Activation of the retinoic acid receptor beta gene by 5-aza-2=-deoxycytidine in human DLD-1 colon carcinoma cells. Anticancer Drugs 8, 56-61.
27. Bovenzi, V., Le, N. L., Cote, S., Sinnett, D., Momparler, L. F., and Momparler, R. L. (1999) DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2=-deoxycytidine. Anticancer Drugs 10, 471-476.
28. Widschwendter, M., Berger, J., Hermann, M., Muller, H. M., Amberger, A., Zeschnigk, M., Widschwendter, A., Abendstein, B., Zeimet, A. G., Daxenbichler, G., and Marth, C. (2000) Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J. Natl. Cancer Inst. 92, 826-832.
29. Sirchia, S. M., Ferguson, A. T., Sironi, E., Subramanyan, S., Orlandi, R., Sukumar, S., and Sacchi, N. (2000) Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Oncogene 19, 1556-1563.
30. Sun, J., Xu, X., Liu, J., Liu, H., Fu, L., and Gu, L. (2010) Epigenetic regulation of retinoic acid receptor beta2 gene in the initiation of breast cancer. Med. Oncol. 1311-1318.
31. Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., and Helin, K. (2006) Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20, 1123-1136.
32. Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., Bergman, Y., Simon, I., and Cedar, H. (2007) Polycombmediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39, 232-236.
33. Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., and Zhang, Y. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039-1043.
34. Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., Berman, D. M., Jenuwein, T., Pruitt, K., Sharkis, S. J., Watkins, D. N., Herman, J. G., and Baylin, S. B. (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39, 237-242.
35. Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., and Laird, P. W. (2007) Epigenetic stem cell signature in cancer. Nat. Genet. 39, 157-158.
36. Mohammad, H. P., Cai, Y., McGarvey, K. M., Easwaran, H., Van Neste, L., Ohm, J. E., O'Hagan, H. M., and Baylin, S. B. (2009) Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res. 69, 6322-6330.
37. Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., VanDerWinden, J. M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., and Fuks, F. (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874.
38. Brinkman, A. B., Gu, H., Bartels, S. J., Zhang, Y., Matarese, F., Simmer, F., Marks, H., Bock, C., Gnirke, A., Meissner, A., and Stunnenberg, H. G. (2012) Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res. 22, 1128-1138.
39. Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G., Otte, A. P., Rubin, M. A., and Chinnaiyan, A. M. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629.
40. LaTulippe, E., Satagopan, J., Smith, A., Scher, H., Scardino, P., Reuter, V., and Gerald, W. L. (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62, 4499-4506.
41. Rhodes, D. R., Sanda, M. G., Otte, A. P., Chinnaiyan, A. M., and Rubin, M. A. (2003) Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J. Natl. Cancer Inst. 95, 661-668.
42. Berezovska, O. P., Glinskii, A. B., Yang, Z., Li, X. M., Hoffman, R. M., and Glinsky, G. V. (2006) Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle 5, 1886-1901.
43. Bachmann, I. M., Halvorsen, O. J., Collett, K., Stefansson, I. M., Straume, O., Haukaas, S. A., Salvesen, H. B., Otte, A. P., and Akslen, L. A. (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol. 24, 268-273.
44. Van Leenders, G. J., Dukers, D., Hessels, D., van den Kieboom, S. W., Hulsbergen, C. A., Witjes, J. A., Otte, A. P., Meijer, C. J., and Raaphorst, F. M. (2007) Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur. Urol. 52, 455-463.
45. Youssef, E. M., Estecio, M. R., and Issa, J. P. (2004) Methylation and regulation of expression of different retinoic acid receptor beta isoforms in human colon cancer. Cancer Biol. Ther. 3, 82-86.
46. Poulain, S., Lacomme, S., Battaglia-Hsu, S. F., du Manoir, S., Brochin, L., Vignaud, J. M., and Martinet, N. (2009) Signalling with retinoids in the human lung: validation of new tools for the expression study of retinoid receptors. BMC Cancer 9, 423.
47. Tost, J., and Gut, I. G. (2007) DNA methylation analysis by pyrosequencing. Nat. Protoc. 2, 2265-2275.
48. Rohde, C., Zhang, Y., Reinhardt, R., and Jeltsch, A. (2010) BISMA-fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences. BMC Bioinformatics 11, 230.
49. Dilworth, F. J., and Chambon, P. (2001) Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20, 3047-3054.
50. Bastien, J., and Rochette-Egly, C. (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328, 1-16.
51. Ren, M., Pozzi, S., Bistulfi, G., Somenzi, G., Rossetti, S., and Sacchi, N. (2005) Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance. Mol. Cell Biol. 25, 10591-10603.
52. Gardiner-Garden, M., and Frommer, M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261-282.
53. Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., and Reinberg, D. (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 16, 2893-2905.
54. Gillespie, R. F., and Gudas, L. J. (2007) Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. J. Mol. Biol. 372, 298-316.
55. Gal-Yam, E. N., Egger, G., Iniguez, L., Holster, H., Einarsson, S., Zhang, X., Lin, J. C., Liang, G., Jones, P. A., and Tanay, A. (2008) Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl. Acad. Sci. U. S. A. 105, 12979-12984.
56. McGarvey, K. M., Greene, E., Fahrner, J. A., Jenuwein, T., and Baylin, S. B. (2007) DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2. Cancer Res. 67, 5097-5102.
57. Li, G., Margueron, R., Ku, M., Chambon, P., Bernstein, B. E., and Reinberg, D. (2010) Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 24, 368-380.
58. Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., and Chang, H. Y. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323.
59. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J., and Lee, J. T. (2008) Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750-756.
60. Kanhere, A., Viiri, K., Araujo, C. C., Rasaiyaah, J., Bouwman, R. D., Whyte, W. A., Pereira, C. F., Brookes, E., Walker, K., Bell, G. W., Pombo, A., Fisher, A. G., Young, R. A., and Jenner, R. G. (2010) Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol. Cell 38, 675-688.
61. Kondo, Y., Shen, L., Cheng, A. S., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi-Addo, B., Gold, D. L., Sekido, Y., Huang, T. H., and Issa, J. P. (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40, 741-750.